SCHEMBL1490423

SCHEMBL1490423

COc1cc(F)c(C(=O)Nc2csc(-c3cccc(Br)c3)c2C(=O)O)c(F)c1F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTGFR P43088 4/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ TNF P01375 1/20 0.39
▸ PRNP P04156 1/20 0.39
▸ NOD2 Q9HC29 1/20 0.39
▸ NOD1 Q9Y239 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ DHODH Q02127 2/20 0.37
▸ GPR35 Q9HC97 1/20 0.36
▸ ABCB1 P08183 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ABCC1 P33527 1/20 0.36
▸ NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490292 0.90 POLB (0.40) MEN1KMT2APOLBLMNANPSR1
SCHEMBL1490555 0.90 DHODH (0.48) MEN1KMT2APOLBDHODHABCB1
SCHEMBL1490434 0.90 POLB (0.39) MEN1KMT2APOLBLMNANPSR1
SCHEMBL1490548 0.90 KMT2A (0.39) MEN1KMT2APRNPPOLBLMNA
SCHEMBL1490533 0.89 MEN1 (0.45) PTGFRMEN1KMT2ATNFPRNP
SCHEMBL1490343 0.89 POLB (0.43) MEN1KMT2APOLBLMNANPSR1
SCHEMBL1490748 0.89 PTGFR (0.43) PTGFRMEN1KMT2ATNFPRNP
SCHEMBL1490475 0.85 TP53 (0.39) MEN1KMT2APRNPPOLBLMNA
SCHEMBL1490424 0.84 LMNA (0.38) MEN1KMT2ATNFPRNPNOD2
SCHEMBL1490427 0.84 MEN1 (0.44) MEN1KMT2APRNPPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 — — US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 PTGFR 3012/4885MEN1 2958/4885KMT2A 4706/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 PTGFR 3012/4885MEN1 2958/4885KMT2A 4706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback